137 related articles for article (PubMed ID: 38572612)
1. Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
Monster JL; Kemp LJ; Busslinger GA; Vliem MJ; Derks LL; Staes AA; Bisseling TM; Clevers H; van der Post RS; Gloerich M
J Pathol; 2024 Jun; 263(2):226-241. PubMed ID: 38572612
[TBL] [Abstract][Full Text] [Related]
2. Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.
Dixon K; Brew T; Farnell D; Godwin TD; Cheung S; Chow C; Ta M; Ho G; Bui M; Douglas JM; Campbell KR; El-Naggar A; Kaurah P; Kalloger SE; Lim HJ; Schaeffer DF; Cochrane D; Guilford P; Huntsman DG
J Pathol; 2021 Jul; 254(3):254-264. PubMed ID: 33797756
[TBL] [Abstract][Full Text] [Related]
3. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and gastric cancer: cause, consequence, and applications.
Liu X; Chu KM
Biomed Res Int; 2014; 2014():637308. PubMed ID: 25184143
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer.
Mimata A; Fukamachi H; Eishi Y; Yuasa Y
Cancer Sci; 2011 May; 102(5):942-50. PubMed ID: 21276134
[TBL] [Abstract][Full Text] [Related]
6. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
7. CD103 (αE Integrin) Undergoes Endosomal Trafficking in Human Dendritic Cells, but Does Not Mediate Epithelial Adhesion.
Swain S; Roe MM; Sebrell TA; Sidar B; Dankoff J; VanAusdol R; Smythies LE; Smith PD; Bimczok D
Front Immunol; 2018; 9():2989. PubMed ID: 30622531
[TBL] [Abstract][Full Text] [Related]
8. Low expression of E-Cadherin and
García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
[TBL] [Abstract][Full Text] [Related]
9. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer.
Minikes AM; Song Y; Feng Y; Yoon C; Yoon SS; Jiang X
Oncogene; 2023 Mar; 42(11):848-857. PubMed ID: 36717701
[TBL] [Abstract][Full Text] [Related]
11. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
12. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
[TBL] [Abstract][Full Text] [Related]
13. RAC1-mediated integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
Zhang J; Fu L; Wang H; Yonemura A; Semba T; Yasuda-Yoshihara N; Nishimura A; Tajiri T; Tong Y; Yasuda T; Uchihara T; Yamazaki M; Okamoto Y; Yamasaki J; Nagano O; Baba H; Ishimoto T
Cancer Lett; 2024 Jun; 591():216901. PubMed ID: 38641311
[TBL] [Abstract][Full Text] [Related]
14. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
Humar B; Guilford P
Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin and LGN align epithelial cell divisions with tissue tension independently of cell shape.
Hart KC; Tan J; Siemers KA; Sim JY; Pruitt BL; Nelson WJ; Gloerich M
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5845-E5853. PubMed ID: 28674014
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.
Humar B; Blair V; Charlton A; More H; Martin I; Guilford P
Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545
[TBL] [Abstract][Full Text] [Related]
18. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
20. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
